Clinical Trial Update: TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial is evaluating TheraT Vectors vaccines in combination with chemotherapy for HPV16-associated head and neck cancers, including HPV-p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Hpv-positive Oropharyngeal Squamous Cell Carcinoma
• Human Papillomavirus Infection
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• TheraT Vectors

Snippet

Sponsor: University of Chicago | Conditions: Human Papilloma Virus, HPV | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING